Wilson Sonsini Goodrich & Rosati represented Halia Therapeutics in the transaction. Halia Therapeutics announced it raised $30 million in Series C financing round led by Todd Pedersen, with continued...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised ThayerMahan, Inc. on the transaction. ThayerMahan, Inc. announced it closed $20 million in follow-on Series C funding led by Hanwha Asset...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Pantera on the transaction. EDX Markets (EDX), a leading digital asset marketplace, announced the launch of its clearinghouse, EDX Clearing,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Hyperline on the transaction. Hyperline, announced that it raised $5.2 million in seed funding. The round was led by Slow Ventures...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised ElevenLabs on the transaction. ElevenLabs announced it has raised an $80 million Series B round co-led by Andreessen Horowitz, Nat Friedman, Daniel Gross, and included participation from Sequoia...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Motif Neurotech on the transaction. Neurotechnology company, Motif Neurotech announced it raised $18.75 million in oversubscribed Series A financing round. The...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Edgewise Therapeutics on the transaction, and Cooley represented the underwriters. Edgewise Therapeutics, Inc. (“Edgewise”) (NASDAQ: EWTX) announced the pricing of an underwritten...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Silo Technologies on the transaction. Silo Technologies announced the completition of a $35 million investment from Koch Disruptive Technologies (KDT). The...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Alector in the offering, and Davis Polk & Wardwell represented the sole book-running manager and underwriter, Cantor Fitzgerald & Co....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Noctrix Health on the transaction. Noctrix Health Inc. announced it has closed a $40 million Series C financing round led...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Cleveland Diagnostics on the transaction. Cleveland Diagnostics, a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Arena BioWorks on patent and transactional matters. Arena BioWorks announced its launch as a biomedical research institute with a mission...
You must be a Standard 1 Year member to access this content.
